Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Tsuji

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2010
mRNA display selection of a high-affinity, Bcl-X(L)-specific binding peptideNobutaka Matsumura, Toru Tsuji, Takeshi Sumida, et al.
International Immunology|April 10, 2015
Anti-Semaphorin 3A neutralization monoclonal antibody prevents sepsis development in lipopolysaccharide-treated miceNaoya Yamashita, Aoi Jitsuki-Takahashi, Miyuki Ogawara, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2010
mRNA display selection of a high-affinity, Bcl-X(L)-specific binding peptideNobutaka Matsumura, Toru Tsuji, Takeshi Sumida, et al.
International Immunology|April 10, 2015
Anti-Semaphorin 3A neutralization monoclonal antibody prevents sepsis development in lipopolysaccharide-treated miceNaoya Yamashita, Aoi Jitsuki-Takahashi, Miyuki Ogawara, et al.
Pageof 2